nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—CHRNB2—Alzheimer's disease	0.139	0.329	CbGaD
Galantamine—ACHE—Rivastigmine—Alzheimer's disease	0.114	0.354	CbGbCtD
Galantamine—ACHE—Donepezil—Alzheimer's disease	0.0908	0.283	CbGbCtD
Galantamine—CHRNA7—Alzheimer's disease	0.0815	0.193	CbGaD
Galantamine—ACHE—Alzheimer's disease	0.0718	0.17	CbGaD
Galantamine—BCHE—Rivastigmine—Alzheimer's disease	0.0684	0.213	CbGbCtD
Galantamine—CHRNA4—Alzheimer's disease	0.0651	0.154	CbGaD
Galantamine—BCHE—Alzheimer's disease	0.0423	0.1	CbGaD
Galantamine—CYP2D6—Alzheimer's disease	0.0232	0.0548	CbGaD
Galantamine—CYP2D6—Rivastigmine—Alzheimer's disease	0.0164	0.051	CbGbCtD
Galantamine—CYP2D6—Donepezil—Alzheimer's disease	0.0131	0.0408	CbGbCtD
Galantamine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0104	0.0324	CbGbCtD
Galantamine—CYP3A4—Donepezil—Alzheimer's disease	0.00832	0.0259	CbGbCtD
Galantamine—CHRNA9—embryo—Alzheimer's disease	0.00276	0.0733	CbGeAlD
Galantamine—CHRNA4—telencephalic ventricle—Alzheimer's disease	0.00185	0.0493	CbGeAlD
Galantamine—CHRNB3—forebrain—Alzheimer's disease	0.00161	0.0429	CbGeAlD
Galantamine—CHRNB3—telencephalon—Alzheimer's disease	0.00148	0.0395	CbGeAlD
Galantamine—CHRNA6—forebrain—Alzheimer's disease	0.00135	0.0358	CbGeAlD
Galantamine—CHRNA6—telencephalon—Alzheimer's disease	0.00124	0.0329	CbGeAlD
Galantamine—CHRNA5—nervous system—Alzheimer's disease	0.000965	0.0257	CbGeAlD
Galantamine—CHRNA5—central nervous system—Alzheimer's disease	0.000929	0.0247	CbGeAlD
Galantamine—CHRNB3—nervous system—Alzheimer's disease	0.000877	0.0233	CbGeAlD
Galantamine—CHRNB3—central nervous system—Alzheimer's disease	0.000844	0.0224	CbGeAlD
Galantamine—CHRNB3—cerebellum—Alzheimer's disease	0.000825	0.0219	CbGeAlD
Galantamine—CHRNB2—forebrain—Alzheimer's disease	0.000774	0.0206	CbGeAlD
Galantamine—CHRNA3—forebrain—Alzheimer's disease	0.000751	0.02	CbGeAlD
Galantamine—CHRNA5—brain—Alzheimer's disease	0.000738	0.0196	CbGeAlD
Galantamine—CHRNA6—nervous system—Alzheimer's disease	0.000732	0.0195	CbGeAlD
Galantamine—CHRNB2—telencephalon—Alzheimer's disease	0.000712	0.0189	CbGeAlD
Galantamine—CHRNA6—central nervous system—Alzheimer's disease	0.000704	0.0187	CbGeAlD
Galantamine—CHRNA2—forebrain—Alzheimer's disease	0.000698	0.0186	CbGeAlD
Galantamine—CHRNA6—cerebellum—Alzheimer's disease	0.000688	0.0183	CbGeAlD
Galantamine—CHRNB3—brain—Alzheimer's disease	0.00067	0.0178	CbGeAlD
Galantamine—CHRNB4—nervous system—Alzheimer's disease	0.000664	0.0177	CbGeAlD
Galantamine—CHRNB4—central nervous system—Alzheimer's disease	0.00064	0.017	CbGeAlD
Galantamine—CHRFAM7A—forebrain—Alzheimer's disease	0.000607	0.0161	CbGeAlD
Galantamine—CHRNA6—brain—Alzheimer's disease	0.000559	0.0149	CbGeAlD
Galantamine—CHRFAM7A—telencephalon—Alzheimer's disease	0.000558	0.0148	CbGeAlD
Galantamine—ACHE—telencephalon—Alzheimer's disease	0.000518	0.0138	CbGeAlD
Galantamine—CHRNB4—brain—Alzheimer's disease	0.000508	0.0135	CbGeAlD
Galantamine—CHRNA7—forebrain—Alzheimer's disease	0.00049	0.013	CbGeAlD
Galantamine—CHRNA4—forebrain—Alzheimer's disease	0.000484	0.0129	CbGeAlD
Galantamine—CHRNA7—telencephalon—Alzheimer's disease	0.000451	0.012	CbGeAlD
Galantamine—CHRNA4—telencephalon—Alzheimer's disease	0.000445	0.0118	CbGeAlD
Galantamine—CHRNB2—nervous system—Alzheimer's disease	0.00042	0.0112	CbGeAlD
Galantamine—CHRNA3—nervous system—Alzheimer's disease	0.000408	0.0108	CbGeAlD
Galantamine—CHRNB2—central nervous system—Alzheimer's disease	0.000405	0.0108	CbGeAlD
Galantamine—CHRNB2—cerebellum—Alzheimer's disease	0.000395	0.0105	CbGeAlD
Galantamine—CHRNA3—central nervous system—Alzheimer's disease	0.000392	0.0104	CbGeAlD
Galantamine—CHRNA3—cerebellum—Alzheimer's disease	0.000384	0.0102	CbGeAlD
Galantamine—CHRNA2—nervous system—Alzheimer's disease	0.000379	0.0101	CbGeAlD
Galantamine—CHRNA2—central nervous system—Alzheimer's disease	0.000365	0.0097	CbGeAlD
Galantamine—CHRNA2—cerebellum—Alzheimer's disease	0.000357	0.00948	CbGeAlD
Galantamine—CHRNA1—brain—Alzheimer's disease	0.000349	0.00928	CbGeAlD
Galantamine—CHRNB1—cerebellum—Alzheimer's disease	0.000332	0.00882	CbGeAlD
Galantamine—CHRFAM7A—nervous system—Alzheimer's disease	0.00033	0.00876	CbGeAlD
Galantamine—CHRNB2—brain—Alzheimer's disease	0.000321	0.00854	CbGeAlD
Galantamine—CHRFAM7A—central nervous system—Alzheimer's disease	0.000317	0.00844	CbGeAlD
Galantamine—CHRNA3—brain—Alzheimer's disease	0.000312	0.00828	CbGeAlD
Galantamine—CHRNA2—brain—Alzheimer's disease	0.00029	0.0077	CbGeAlD
Galantamine—ACHE—cerebellum—Alzheimer's disease	0.000288	0.00765	CbGeAlD
Galantamine—BCHE—forebrain—Alzheimer's disease	0.000277	0.00736	CbGeAlD
Galantamine—CHRNB1—brain—Alzheimer's disease	0.000269	0.00716	CbGeAlD
Galantamine—CHRNA7—nervous system—Alzheimer's disease	0.000266	0.00708	CbGeAlD
Galantamine—CHRNA4—nervous system—Alzheimer's disease	0.000263	0.00698	CbGeAlD
Galantamine—CHRNA7—central nervous system—Alzheimer's disease	0.000256	0.00681	CbGeAlD
Galantamine—Dihydrocodeine—CYP2D6—Alzheimer's disease	0.000255	0.222	CrCbGaD
Galantamine—BCHE—telencephalon—Alzheimer's disease	0.000254	0.00677	CbGeAlD
Galantamine—CHRNA4—central nervous system—Alzheimer's disease	0.000253	0.00672	CbGeAlD
Galantamine—CHRFAM7A—brain—Alzheimer's disease	0.000252	0.0067	CbGeAlD
Galantamine—CHRNA4—cerebellum—Alzheimer's disease	0.000247	0.00657	CbGeAlD
Galantamine—ACHE—brain—Alzheimer's disease	0.000234	0.00621	CbGeAlD
Galantamine—Ethylmorphine—CYP2D6—Alzheimer's disease	0.000214	0.186	CrCbGaD
Galantamine—CHRNA7—brain—Alzheimer's disease	0.000203	0.00541	CbGeAlD
Galantamine—CHRNA4—brain—Alzheimer's disease	0.000201	0.00534	CbGeAlD
Galantamine—Hydrocodone—CYP2D6—Alzheimer's disease	0.000195	0.17	CrCbGaD
Galantamine—CYP2D6—forebrain—Alzheimer's disease	0.000183	0.00487	CbGeAlD
Galantamine—Depression—Donepezil—Alzheimer's disease	0.000181	0.00164	CcSEcCtD
Galantamine—Dysphagia—Rivastigmine—Alzheimer's disease	0.000181	0.00164	CcSEcCtD
Galantamine—Renal failure—Donepezil—Alzheimer's disease	0.000179	0.00162	CcSEcCtD
Galantamine—Oxycodone—CYP2D6—Alzheimer's disease	0.000178	0.155	CrCbGaD
Galantamine—Bronchitis—Memantine—Alzheimer's disease	0.000178	0.00161	CcSEcCtD
Galantamine—Urinary tract infection—Donepezil—Alzheimer's disease	0.000177	0.0016	CcSEcCtD
Galantamine—Bronchitis—Rivastigmine—Alzheimer's disease	0.000174	0.00158	CcSEcCtD
Galantamine—Haematuria—Donepezil—Alzheimer's disease	0.000173	0.00157	CcSEcCtD
Galantamine—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.000172	0.00156	CcSEcCtD
Galantamine—Epistaxis—Donepezil—Alzheimer's disease	0.000171	0.00155	CcSEcCtD
Galantamine—Pollakiuria—Memantine—Alzheimer's disease	0.000171	0.00155	CcSEcCtD
Galantamine—Codeine—CYP2D6—Alzheimer's disease	0.00017	0.148	CrCbGaD
Galantamine—CYP2D6—telencephalon—Alzheimer's disease	0.000169	0.00448	CbGeAlD
Galantamine—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000168	0.00152	CcSEcCtD
Galantamine—Weight decreased—Memantine—Alzheimer's disease	0.000167	0.00152	CcSEcCtD
Galantamine—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000167	0.00151	CcSEcCtD
Galantamine—Hyperglycaemia—Memantine—Alzheimer's disease	0.000167	0.00151	CcSEcCtD
Galantamine—Bradycardia—Donepezil—Alzheimer's disease	0.000166	0.0015	CcSEcCtD
Galantamine—Pneumonia—Memantine—Alzheimer's disease	0.000166	0.0015	CcSEcCtD
Galantamine—Depression—Memantine—Alzheimer's disease	0.000164	0.00149	CcSEcCtD
Galantamine—Haemoglobin—Donepezil—Alzheimer's disease	0.000164	0.00148	CcSEcCtD
Galantamine—Weight decreased—Rivastigmine—Alzheimer's disease	0.000164	0.00148	CcSEcCtD
Galantamine—Rhinitis—Donepezil—Alzheimer's disease	0.000163	0.00148	CcSEcCtD
Galantamine—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000163	0.00148	CcSEcCtD
Galantamine—Haemorrhage—Donepezil—Alzheimer's disease	0.000163	0.00148	CcSEcCtD
Galantamine—Hepatitis—Donepezil—Alzheimer's disease	0.000163	0.00148	CcSEcCtD
Galantamine—Pneumonia—Rivastigmine—Alzheimer's disease	0.000162	0.00147	CcSEcCtD
Galantamine—Hallucination—Donepezil—Alzheimer's disease	0.000162	0.00147	CcSEcCtD
Galantamine—Renal failure—Memantine—Alzheimer's disease	0.000162	0.00147	CcSEcCtD
Galantamine—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000162	0.00146	CcSEcCtD
Galantamine—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000161	0.00146	CcSEcCtD
Galantamine—Depression—Rivastigmine—Alzheimer's disease	0.000161	0.00146	CcSEcCtD
Galantamine—Oedema peripheral—Donepezil—Alzheimer's disease	0.000161	0.00145	CcSEcCtD
Galantamine—Urinary tract infection—Memantine—Alzheimer's disease	0.00016	0.00145	CcSEcCtD
Galantamine—Urethral disorder—Donepezil—Alzheimer's disease	0.00016	0.00145	CcSEcCtD
Galantamine—Renal failure—Rivastigmine—Alzheimer's disease	0.000159	0.00144	CcSEcCtD
Galantamine—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000158	0.00143	CcSEcCtD
Galantamine—Haematuria—Memantine—Alzheimer's disease	0.000157	0.00142	CcSEcCtD
Galantamine—Visual impairment—Donepezil—Alzheimer's disease	0.000157	0.00142	CcSEcCtD
Galantamine—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000157	0.00142	CcSEcCtD
Galantamine—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000156	0.00141	CcSEcCtD
Galantamine—Epistaxis—Memantine—Alzheimer's disease	0.000156	0.00141	CcSEcCtD
Galantamine—Haematuria—Rivastigmine—Alzheimer's disease	0.000154	0.00139	CcSEcCtD
Galantamine—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000153	0.00138	CcSEcCtD
Galantamine—Epistaxis—Rivastigmine—Alzheimer's disease	0.000152	0.00138	CcSEcCtD
Galantamine—Tinnitus—Donepezil—Alzheimer's disease	0.000152	0.00138	CcSEcCtD
Galantamine—Bradycardia—Memantine—Alzheimer's disease	0.000151	0.00136	CcSEcCtD
Galantamine—BCHE—nervous system—Alzheimer's disease	0.00015	0.00399	CbGeAlD
Galantamine—Haemoglobin—Memantine—Alzheimer's disease	0.000149	0.00135	CcSEcCtD
Galantamine—Rhinitis—Memantine—Alzheimer's disease	0.000148	0.00134	CcSEcCtD
Galantamine—Haemorrhage—Memantine—Alzheimer's disease	0.000148	0.00134	CcSEcCtD
Galantamine—Hepatitis—Memantine—Alzheimer's disease	0.000148	0.00134	CcSEcCtD
Galantamine—Bradycardia—Rivastigmine—Alzheimer's disease	0.000147	0.00134	CcSEcCtD
Galantamine—Hallucination—Memantine—Alzheimer's disease	0.000147	0.00133	CcSEcCtD
Galantamine—Urinary tract disorder—Memantine—Alzheimer's disease	0.000146	0.00132	CcSEcCtD
Galantamine—Oedema peripheral—Memantine—Alzheimer's disease	0.000146	0.00132	CcSEcCtD
Galantamine—Arrhythmia—Donepezil—Alzheimer's disease	0.000146	0.00132	CcSEcCtD
Galantamine—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000146	0.00132	CcSEcCtD
Galantamine—Connective tissue disorder—Memantine—Alzheimer's disease	0.000145	0.00132	CcSEcCtD
Galantamine—Rhinitis—Rivastigmine—Alzheimer's disease	0.000145	0.00131	CcSEcCtD
Galantamine—Urethral disorder—Memantine—Alzheimer's disease	0.000145	0.00131	CcSEcCtD
Galantamine—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000145	0.00131	CcSEcCtD
Galantamine—Hepatitis—Rivastigmine—Alzheimer's disease	0.000145	0.00131	CcSEcCtD
Galantamine—BCHE—central nervous system—Alzheimer's disease	0.000145	0.00385	CbGeAlD
Galantamine—Hallucination—Rivastigmine—Alzheimer's disease	0.000144	0.0013	CcSEcCtD
Galantamine—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000143	0.0013	CcSEcCtD
Galantamine—Mental disorder—Donepezil—Alzheimer's disease	0.000143	0.00129	CcSEcCtD
Galantamine—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000143	0.00129	CcSEcCtD
Galantamine—Visual impairment—Memantine—Alzheimer's disease	0.000143	0.00129	CcSEcCtD
Galantamine—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000142	0.00129	CcSEcCtD
Galantamine—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000142	0.00129	CcSEcCtD
Galantamine—Malnutrition—Donepezil—Alzheimer's disease	0.000142	0.00129	CcSEcCtD
Galantamine—BCHE—cerebellum—Alzheimer's disease	0.000141	0.00376	CbGeAlD
Galantamine—Flatulence—Donepezil—Alzheimer's disease	0.00014	0.00127	CcSEcCtD
Galantamine—Visual impairment—Rivastigmine—Alzheimer's disease	0.00014	0.00126	CcSEcCtD
Galantamine—Tension—Donepezil—Alzheimer's disease	0.000139	0.00126	CcSEcCtD
Galantamine—Dysgeusia—Donepezil—Alzheimer's disease	0.000139	0.00126	CcSEcCtD
Galantamine—Eye disorder—Memantine—Alzheimer's disease	0.000138	0.00125	CcSEcCtD
Galantamine—Tinnitus—Memantine—Alzheimer's disease	0.000138	0.00125	CcSEcCtD
Galantamine—Nervousness—Donepezil—Alzheimer's disease	0.000138	0.00125	CcSEcCtD
Galantamine—Morphine—CYP2D6—Alzheimer's disease	0.000138	0.12	CrCbGaD
Galantamine—Cardiac disorder—Memantine—Alzheimer's disease	0.000137	0.00124	CcSEcCtD
Galantamine—Flushing—Memantine—Alzheimer's disease	0.000137	0.00124	CcSEcCtD
Galantamine—Back pain—Donepezil—Alzheimer's disease	0.000137	0.00124	CcSEcCtD
Galantamine—Muscle spasms—Donepezil—Alzheimer's disease	0.000136	0.00124	CcSEcCtD
Galantamine—Eye disorder—Rivastigmine—Alzheimer's disease	0.000135	0.00123	CcSEcCtD
Galantamine—Tinnitus—Rivastigmine—Alzheimer's disease	0.000135	0.00122	CcSEcCtD
Galantamine—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000134	0.00122	CcSEcCtD
Galantamine—Flushing—Rivastigmine—Alzheimer's disease	0.000134	0.00122	CcSEcCtD
Galantamine—Angiopathy—Memantine—Alzheimer's disease	0.000134	0.00122	CcSEcCtD
Galantamine—Vision blurred—Donepezil—Alzheimer's disease	0.000134	0.00121	CcSEcCtD
Galantamine—Immune system disorder—Memantine—Alzheimer's disease	0.000134	0.00121	CcSEcCtD
Galantamine—Tremor—Donepezil—Alzheimer's disease	0.000133	0.0012	CcSEcCtD
Galantamine—Arrhythmia—Memantine—Alzheimer's disease	0.000132	0.0012	CcSEcCtD
Galantamine—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000132	0.00119	CcSEcCtD
Galantamine—Angiopathy—Rivastigmine—Alzheimer's disease	0.000131	0.00119	CcSEcCtD
Galantamine—Anaemia—Donepezil—Alzheimer's disease	0.000131	0.00119	CcSEcCtD
Galantamine—Agitation—Donepezil—Alzheimer's disease	0.00013	0.00118	CcSEcCtD
Galantamine—Mental disorder—Memantine—Alzheimer's disease	0.00013	0.00117	CcSEcCtD
Galantamine—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000129	0.00117	CcSEcCtD
Galantamine—Malnutrition—Memantine—Alzheimer's disease	0.000129	0.00117	CcSEcCtD
Galantamine—Malaise—Donepezil—Alzheimer's disease	0.000128	0.00116	CcSEcCtD
Galantamine—Vertigo—Donepezil—Alzheimer's disease	0.000128	0.00115	CcSEcCtD
Galantamine—Syncope—Donepezil—Alzheimer's disease	0.000127	0.00115	CcSEcCtD
Galantamine—Flatulence—Memantine—Alzheimer's disease	0.000127	0.00115	CcSEcCtD
Galantamine—Mental disorder—Rivastigmine—Alzheimer's disease	0.000127	0.00115	CcSEcCtD
Galantamine—Tension—Memantine—Alzheimer's disease	0.000126	0.00115	CcSEcCtD
Galantamine—Dysgeusia—Memantine—Alzheimer's disease	0.000126	0.00114	CcSEcCtD
Galantamine—Malnutrition—Rivastigmine—Alzheimer's disease	0.000126	0.00114	CcSEcCtD
Galantamine—Nervousness—Memantine—Alzheimer's disease	0.000125	0.00113	CcSEcCtD
Galantamine—Loss of consciousness—Donepezil—Alzheimer's disease	0.000125	0.00113	CcSEcCtD
Galantamine—Back pain—Memantine—Alzheimer's disease	0.000125	0.00113	CcSEcCtD
Galantamine—Flatulence—Rivastigmine—Alzheimer's disease	0.000124	0.00113	CcSEcCtD
Galantamine—Cough—Donepezil—Alzheimer's disease	0.000124	0.00112	CcSEcCtD
Galantamine—Tension—Rivastigmine—Alzheimer's disease	0.000124	0.00112	CcSEcCtD
Galantamine—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000123	0.00112	CcSEcCtD
Galantamine—Convulsion—Donepezil—Alzheimer's disease	0.000123	0.00111	CcSEcCtD
Galantamine—Hypertension—Donepezil—Alzheimer's disease	0.000123	0.00111	CcSEcCtD
Galantamine—Nervousness—Rivastigmine—Alzheimer's disease	0.000122	0.00111	CcSEcCtD
Galantamine—Back pain—Rivastigmine—Alzheimer's disease	0.000122	0.0011	CcSEcCtD
Galantamine—Vision blurred—Memantine—Alzheimer's disease	0.000121	0.0011	CcSEcCtD
Galantamine—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000121	0.0011	CcSEcCtD
Galantamine—Arthralgia—Donepezil—Alzheimer's disease	0.000121	0.00109	CcSEcCtD
Galantamine—Chest pain—Donepezil—Alzheimer's disease	0.000121	0.00109	CcSEcCtD
Galantamine—Myalgia—Donepezil—Alzheimer's disease	0.000121	0.00109	CcSEcCtD
Galantamine—Tremor—Memantine—Alzheimer's disease	0.000121	0.00109	CcSEcCtD
Galantamine—Anxiety—Donepezil—Alzheimer's disease	0.00012	0.00109	CcSEcCtD
Galantamine—Ill-defined disorder—Memantine—Alzheimer's disease	0.00012	0.00108	CcSEcCtD
Galantamine—Discomfort—Donepezil—Alzheimer's disease	0.000119	0.00108	CcSEcCtD
Galantamine—Anaemia—Memantine—Alzheimer's disease	0.000119	0.00108	CcSEcCtD
Galantamine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000119	0.00108	CcSEcCtD
Galantamine—Agitation—Memantine—Alzheimer's disease	0.000118	0.00107	CcSEcCtD
Galantamine—Dry mouth—Donepezil—Alzheimer's disease	0.000118	0.00107	CcSEcCtD
Galantamine—Tremor—Rivastigmine—Alzheimer's disease	0.000118	0.00107	CcSEcCtD
Galantamine—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000117	0.00106	CcSEcCtD
Galantamine—Confusional state—Donepezil—Alzheimer's disease	0.000117	0.00106	CcSEcCtD
Galantamine—Anaemia—Rivastigmine—Alzheimer's disease	0.000117	0.00106	CcSEcCtD
Galantamine—Malaise—Memantine—Alzheimer's disease	0.000116	0.00105	CcSEcCtD
Galantamine—Agitation—Rivastigmine—Alzheimer's disease	0.000116	0.00105	CcSEcCtD
Galantamine—Vertigo—Memantine—Alzheimer's disease	0.000116	0.00105	CcSEcCtD
Galantamine—Syncope—Memantine—Alzheimer's disease	0.000116	0.00105	CcSEcCtD
Galantamine—BCHE—brain—Alzheimer's disease	0.000115	0.00305	CbGeAlD
Galantamine—Shock—Donepezil—Alzheimer's disease	0.000114	0.00103	CcSEcCtD
Galantamine—Palpitations—Memantine—Alzheimer's disease	0.000114	0.00103	CcSEcCtD
Galantamine—Malaise—Rivastigmine—Alzheimer's disease	0.000114	0.00103	CcSEcCtD
Galantamine—Nervous system disorder—Donepezil—Alzheimer's disease	0.000114	0.00103	CcSEcCtD
Galantamine—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000113	0.00103	CcSEcCtD
Galantamine—Vertigo—Rivastigmine—Alzheimer's disease	0.000113	0.00103	CcSEcCtD
Galantamine—Loss of consciousness—Memantine—Alzheimer's disease	0.000113	0.00103	CcSEcCtD
Galantamine—Syncope—Rivastigmine—Alzheimer's disease	0.000113	0.00102	CcSEcCtD
Galantamine—Cough—Memantine—Alzheimer's disease	0.000112	0.00102	CcSEcCtD
Galantamine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000112	0.00101	CcSEcCtD
Galantamine—Convulsion—Memantine—Alzheimer's disease	0.000112	0.00101	CcSEcCtD
Galantamine—Palpitations—Rivastigmine—Alzheimer's disease	0.000111	0.00101	CcSEcCtD
Galantamine—Hypertension—Memantine—Alzheimer's disease	0.000111	0.00101	CcSEcCtD
Galantamine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000111	0.001	CcSEcCtD
Galantamine—Anorexia—Donepezil—Alzheimer's disease	0.00011	0.001	CcSEcCtD
Galantamine—Cough—Rivastigmine—Alzheimer's disease	0.00011	0.000996	CcSEcCtD
Galantamine—Myalgia—Memantine—Alzheimer's disease	0.00011	0.000994	CcSEcCtD
Galantamine—Chest pain—Memantine—Alzheimer's disease	0.00011	0.000994	CcSEcCtD
Galantamine—Arthralgia—Memantine—Alzheimer's disease	0.00011	0.000994	CcSEcCtD
Galantamine—Anxiety—Memantine—Alzheimer's disease	0.000109	0.00099	CcSEcCtD
Galantamine—Convulsion—Rivastigmine—Alzheimer's disease	0.000109	0.000989	CcSEcCtD
Galantamine—Hypertension—Rivastigmine—Alzheimer's disease	0.000109	0.000986	CcSEcCtD
Galantamine—Discomfort—Memantine—Alzheimer's disease	0.000108	0.000982	CcSEcCtD
Galantamine—Hypotension—Donepezil—Alzheimer's disease	0.000108	0.00098	CcSEcCtD
Galantamine—Arthralgia—Rivastigmine—Alzheimer's disease	0.000107	0.000972	CcSEcCtD
Galantamine—Chest pain—Rivastigmine—Alzheimer's disease	0.000107	0.000972	CcSEcCtD
Galantamine—Myalgia—Rivastigmine—Alzheimer's disease	0.000107	0.000972	CcSEcCtD
Galantamine—Dry mouth—Memantine—Alzheimer's disease	0.000107	0.000972	CcSEcCtD
Galantamine—Anxiety—Rivastigmine—Alzheimer's disease	0.000107	0.000969	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000107	0.000965	CcSEcCtD
Galantamine—Confusional state—Memantine—Alzheimer's disease	0.000106	0.00096	CcSEcCtD
Galantamine—Discomfort—Rivastigmine—Alzheimer's disease	0.000106	0.00096	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000106	0.000956	CcSEcCtD
Galantamine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000105	0.000951	CcSEcCtD
Galantamine—Insomnia—Donepezil—Alzheimer's disease	0.000105	0.000949	CcSEcCtD
Galantamine—Paraesthesia—Donepezil—Alzheimer's disease	0.000104	0.000942	CcSEcCtD
Galantamine—Confusional state—Rivastigmine—Alzheimer's disease	0.000104	0.00094	CcSEcCtD
Galantamine—Shock—Memantine—Alzheimer's disease	0.000103	0.000937	CcSEcCtD
Galantamine—Nervous system disorder—Memantine—Alzheimer's disease	0.000103	0.000934	CcSEcCtD
Galantamine—Somnolence—Donepezil—Alzheimer's disease	0.000103	0.000933	CcSEcCtD
Galantamine—Thrombocytopenia—Memantine—Alzheimer's disease	0.000103	0.000933	CcSEcCtD
Galantamine—Tachycardia—Memantine—Alzheimer's disease	0.000103	0.00093	CcSEcCtD
Galantamine—Skin disorder—Memantine—Alzheimer's disease	0.000102	0.000925	CcSEcCtD
Galantamine—Dyspepsia—Donepezil—Alzheimer's disease	0.000102	0.000923	CcSEcCtD
Galantamine—Hyperhidrosis—Memantine—Alzheimer's disease	0.000102	0.000921	CcSEcCtD
Galantamine—Shock—Rivastigmine—Alzheimer's disease	0.000101	0.000917	CcSEcCtD
Galantamine—CYP3A4—nervous system—Alzheimer's disease	0.000101	0.00269	CbGeAlD
Galantamine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000101	0.000914	CcSEcCtD
Galantamine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000101	0.000912	CcSEcCtD
Galantamine—Decreased appetite—Donepezil—Alzheimer's disease	0.000101	0.000912	CcSEcCtD
Galantamine—Tachycardia—Rivastigmine—Alzheimer's disease	0.0001	0.000909	CcSEcCtD
Galantamine—Anorexia—Memantine—Alzheimer's disease	0.0001	0.000908	CcSEcCtD
Galantamine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.0001	0.000906	CcSEcCtD
Galantamine—Skin disorder—Rivastigmine—Alzheimer's disease	0.0001	0.000905	CcSEcCtD
Galantamine—Fatigue—Donepezil—Alzheimer's disease	9.99e-05	0.000904	CcSEcCtD
Galantamine—CYP2D6—nervous system—Alzheimer's disease	9.95e-05	0.00265	CbGeAlD
Galantamine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	9.95e-05	0.000901	CcSEcCtD
Galantamine—Constipation—Donepezil—Alzheimer's disease	9.91e-05	0.000897	CcSEcCtD
Galantamine—Hypotension—Memantine—Alzheimer's disease	9.83e-05	0.00089	CcSEcCtD
Galantamine—Anorexia—Rivastigmine—Alzheimer's disease	9.81e-05	0.000888	CcSEcCtD
Galantamine—CYP3A4—central nervous system—Alzheimer's disease	9.74e-05	0.00259	CbGeAlD
Galantamine—Hypotension—Rivastigmine—Alzheimer's disease	9.62e-05	0.000871	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Memantine—Alzheimer's disease	9.58e-05	0.000868	CcSEcCtD
Galantamine—CYP2D6—central nervous system—Alzheimer's disease	9.58e-05	0.00255	CbGeAlD
Galantamine—Feeling abnormal—Donepezil—Alzheimer's disease	9.55e-05	0.000864	CcSEcCtD
Galantamine—Insomnia—Memantine—Alzheimer's disease	9.51e-05	0.000861	CcSEcCtD
Galantamine—Gastrointestinal pain—Donepezil—Alzheimer's disease	9.47e-05	0.000858	CcSEcCtD
Galantamine—Paraesthesia—Memantine—Alzheimer's disease	9.45e-05	0.000855	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	9.38e-05	0.000849	CcSEcCtD
Galantamine—CYP2D6—cerebellum—Alzheimer's disease	9.37e-05	0.00249	CbGeAlD
Galantamine—Somnolence—Memantine—Alzheimer's disease	9.35e-05	0.000847	CcSEcCtD
Galantamine—Insomnia—Rivastigmine—Alzheimer's disease	9.31e-05	0.000843	CcSEcCtD
Galantamine—Dyspepsia—Memantine—Alzheimer's disease	9.26e-05	0.000838	CcSEcCtD
Galantamine—Paraesthesia—Rivastigmine—Alzheimer's disease	9.24e-05	0.000837	CcSEcCtD
Galantamine—Abdominal pain—Donepezil—Alzheimer's disease	9.16e-05	0.000829	CcSEcCtD
Galantamine—Body temperature increased—Donepezil—Alzheimer's disease	9.16e-05	0.000829	CcSEcCtD
Galantamine—Somnolence—Rivastigmine—Alzheimer's disease	9.15e-05	0.000828	CcSEcCtD
Galantamine—Decreased appetite—Memantine—Alzheimer's disease	9.14e-05	0.000828	CcSEcCtD
Galantamine—Gastrointestinal disorder—Memantine—Alzheimer's disease	9.08e-05	0.000822	CcSEcCtD
Galantamine—Fatigue—Memantine—Alzheimer's disease	9.07e-05	0.000821	CcSEcCtD
Galantamine—Dyspepsia—Rivastigmine—Alzheimer's disease	9.06e-05	0.00082	CcSEcCtD
Galantamine—Constipation—Memantine—Alzheimer's disease	8.99e-05	0.000815	CcSEcCtD
Galantamine—Decreased appetite—Rivastigmine—Alzheimer's disease	8.95e-05	0.00081	CcSEcCtD
Galantamine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	8.88e-05	0.000804	CcSEcCtD
Galantamine—Fatigue—Rivastigmine—Alzheimer's disease	8.87e-05	0.000803	CcSEcCtD
Galantamine—Constipation—Rivastigmine—Alzheimer's disease	8.8e-05	0.000797	CcSEcCtD
Galantamine—Feeling abnormal—Memantine—Alzheimer's disease	8.67e-05	0.000785	CcSEcCtD
Galantamine—Gastrointestinal pain—Memantine—Alzheimer's disease	8.6e-05	0.000779	CcSEcCtD
Galantamine—Hypersensitivity—Donepezil—Alzheimer's disease	8.54e-05	0.000773	CcSEcCtD
Galantamine—Feeling abnormal—Rivastigmine—Alzheimer's disease	8.48e-05	0.000768	CcSEcCtD
Galantamine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	8.41e-05	0.000762	CcSEcCtD
Galantamine—Abdominal pain—Memantine—Alzheimer's disease	8.32e-05	0.000753	CcSEcCtD
Galantamine—Body temperature increased—Memantine—Alzheimer's disease	8.32e-05	0.000753	CcSEcCtD
Galantamine—Asthenia—Donepezil—Alzheimer's disease	8.31e-05	0.000753	CcSEcCtD
Galantamine—Body temperature increased—Rivastigmine—Alzheimer's disease	8.13e-05	0.000737	CcSEcCtD
Galantamine—Abdominal pain—Rivastigmine—Alzheimer's disease	8.13e-05	0.000737	CcSEcCtD
Galantamine—Diarrhoea—Donepezil—Alzheimer's disease	7.93e-05	0.000718	CcSEcCtD
Galantamine—Hypersensitivity—Memantine—Alzheimer's disease	7.75e-05	0.000702	CcSEcCtD
Galantamine—Dizziness—Donepezil—Alzheimer's disease	7.66e-05	0.000694	CcSEcCtD
Galantamine—CYP2D6—brain—Alzheimer's disease	7.61e-05	0.00202	CbGeAlD
Galantamine—Hypersensitivity—Rivastigmine—Alzheimer's disease	7.58e-05	0.000687	CcSEcCtD
Galantamine—Asthenia—Memantine—Alzheimer's disease	7.55e-05	0.000683	CcSEcCtD
Galantamine—Asthenia—Rivastigmine—Alzheimer's disease	7.38e-05	0.000669	CcSEcCtD
Galantamine—Vomiting—Donepezil—Alzheimer's disease	7.37e-05	0.000667	CcSEcCtD
Galantamine—Rash—Donepezil—Alzheimer's disease	7.3e-05	0.000661	CcSEcCtD
Galantamine—Dermatitis—Donepezil—Alzheimer's disease	7.3e-05	0.000661	CcSEcCtD
Galantamine—Headache—Donepezil—Alzheimer's disease	7.26e-05	0.000657	CcSEcCtD
Galantamine—Diarrhoea—Memantine—Alzheimer's disease	7.2e-05	0.000652	CcSEcCtD
Galantamine—Diarrhoea—Rivastigmine—Alzheimer's disease	7.04e-05	0.000638	CcSEcCtD
Galantamine—Dizziness—Memantine—Alzheimer's disease	6.96e-05	0.00063	CcSEcCtD
Galantamine—Nausea—Donepezil—Alzheimer's disease	6.88e-05	0.000623	CcSEcCtD
Galantamine—Dizziness—Rivastigmine—Alzheimer's disease	6.8e-05	0.000616	CcSEcCtD
Galantamine—Vomiting—Memantine—Alzheimer's disease	6.69e-05	0.000606	CcSEcCtD
Galantamine—Rash—Memantine—Alzheimer's disease	6.63e-05	0.000601	CcSEcCtD
Galantamine—Dermatitis—Memantine—Alzheimer's disease	6.63e-05	0.0006	CcSEcCtD
Galantamine—Headache—Memantine—Alzheimer's disease	6.59e-05	0.000597	CcSEcCtD
Galantamine—Vomiting—Rivastigmine—Alzheimer's disease	6.54e-05	0.000592	CcSEcCtD
Galantamine—Rash—Rivastigmine—Alzheimer's disease	6.49e-05	0.000588	CcSEcCtD
Galantamine—Dermatitis—Rivastigmine—Alzheimer's disease	6.48e-05	0.000587	CcSEcCtD
Galantamine—Headache—Rivastigmine—Alzheimer's disease	6.45e-05	0.000584	CcSEcCtD
Galantamine—Nausea—Memantine—Alzheimer's disease	6.25e-05	0.000566	CcSEcCtD
Galantamine—Nausea—Rivastigmine—Alzheimer's disease	6.11e-05	0.000553	CcSEcCtD
Galantamine—BCHE—Metabolism of proteins—TPP1—Alzheimer's disease	1.19e-05	0.000111	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—BCHE—Alzheimer's disease	1.19e-05	0.000111	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—PRKCG—Alzheimer's disease	1.16e-05	0.000109	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—DLG4—Alzheimer's disease	1.16e-05	0.000108	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—CALM1—Alzheimer's disease	1.16e-05	0.000108	CbGpPWpGaD
Galantamine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	1.15e-05	0.000107	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	1.15e-05	0.000107	CbGpPWpGaD
Galantamine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	1.13e-05	0.000106	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—GRIN2B—Alzheimer's disease	1.13e-05	0.000106	CbGpPWpGaD
Galantamine—CHRNA4—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	1.12e-05	0.000105	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—PLCB1—Alzheimer's disease	1.12e-05	0.000105	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	1.12e-05	0.000104	CbGpPWpGaD
Galantamine—CHRNA3—Neuronal System—CREB1—Alzheimer's disease	1.11e-05	0.000104	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	1.1e-05	0.000103	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	1.08e-05	0.000101	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	1.07e-05	9.99e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—DHCR24—Alzheimer's disease	1.07e-05	9.96e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—ADAMTS4—Alzheimer's disease	1.07e-05	9.96e-05	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	1.06e-05	9.87e-05	CbGpPWpGaD
Galantamine—CHRNA7—Neuronal System—CREB1—Alzheimer's disease	1.06e-05	9.86e-05	CbGpPWpGaD
Galantamine—CHRNA1—Neuronal System—CREB1—Alzheimer's disease	1.05e-05	9.76e-05	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	1.04e-05	9.74e-05	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—DLG4—Alzheimer's disease	1.03e-05	9.66e-05	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—MAOB—Alzheimer's disease	1.02e-05	9.51e-05	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	1.02e-05	9.5e-05	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	1.01e-05	9.48e-05	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—GRIN2B—Alzheimer's disease	1.01e-05	9.45e-05	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—CALM1—Alzheimer's disease	1.01e-05	9.39e-05	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—PLCB1—Alzheimer's disease	1e-05	9.34e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	9.95e-06	9.29e-05	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—CREB1—Alzheimer's disease	9.93e-06	9.27e-05	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	9.66e-06	9.02e-05	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—TP53—Alzheimer's disease	9.54e-06	8.91e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—DHCR24—Alzheimer's disease	9.52e-06	8.89e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—ADAMTS4—Alzheimer's disease	9.51e-06	8.88e-05	CbGpPWpGaD
Galantamine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	9.5e-06	8.87e-05	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	9.36e-06	8.74e-05	CbGpPWpGaD
Galantamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	9.32e-06	8.7e-05	CbGpPWpGaD
Galantamine—ACHE—ATF-2 transcription factor network—IL6—Alzheimer's disease	9.25e-06	8.64e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	9.24e-06	8.63e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CA4—Alzheimer's disease	9.07e-06	8.47e-05	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	9.05e-06	8.46e-05	CbGpPWpGaD
Galantamine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	9e-06	8.4e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	8.87e-06	8.29e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	8.87e-06	8.28e-05	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—IL6—Alzheimer's disease	8.73e-06	8.15e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—MME—Alzheimer's disease	8.69e-06	8.12e-05	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	8.61e-06	8.04e-05	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—CREB1—Alzheimer's disease	8.61e-06	8.04e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GAPDHS—Alzheimer's disease	8.53e-06	7.97e-05	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	8.42e-06	7.86e-05	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	8.35e-06	7.8e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	8.32e-06	7.77e-05	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—PRKCG—Alzheimer's disease	8.29e-06	7.74e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CA4—Alzheimer's disease	8.09e-06	7.56e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ATP5A1—Alzheimer's disease	8.09e-06	7.55e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—HSPD1—Alzheimer's disease	8.08e-06	7.55e-05	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	8.02e-06	7.49e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	8e-06	7.47e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	7.91e-06	7.39e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—MME—Alzheimer's disease	7.76e-06	7.24e-05	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—PTGS1—Alzheimer's disease	7.72e-06	7.21e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PLD3—Alzheimer's disease	7.71e-06	7.2e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	7.62e-06	7.12e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GAPDHS—Alzheimer's disease	7.61e-06	7.11e-05	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—PRKCG—Alzheimer's disease	7.4e-06	6.91e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—HSD17B10—Alzheimer's disease	7.4e-06	6.91e-05	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	7.38e-06	6.89e-05	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	7.31e-06	6.82e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	7.23e-06	6.75e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ATP5A1—Alzheimer's disease	7.21e-06	6.74e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—HSPD1—Alzheimer's disease	7.21e-06	6.73e-05	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—CALM1—Alzheimer's disease	7.17e-06	6.7e-05	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	7.15e-06	6.68e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP46A1—Alzheimer's disease	7.12e-06	6.65e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	6.98e-06	6.52e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PLD3—Alzheimer's disease	6.88e-06	6.43e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	6.88e-06	6.43e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ND1—Alzheimer's disease	6.88e-06	6.42e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—EIF2S1—Alzheimer's disease	6.83e-06	6.38e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	6.8e-06	6.35e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	6.72e-06	6.28e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	6.66e-06	6.22e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	6.63e-06	6.19e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—HSD17B10—Alzheimer's disease	6.6e-06	6.16e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	6.45e-06	6.02e-05	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—CALM1—Alzheimer's disease	6.4e-06	5.98e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP46A1—Alzheimer's disease	6.35e-06	5.93e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—CTSD—Alzheimer's disease	6.31e-06	5.89e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	6.16e-06	5.75e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	6.15e-06	5.74e-05	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—CREB1—Alzheimer's disease	6.14e-06	5.74e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ND1—Alzheimer's disease	6.13e-06	5.73e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—EIF2S1—Alzheimer's disease	6.09e-06	5.69e-05	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	5.96e-06	5.56e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—ACHE—Alzheimer's disease	5.95e-06	5.55e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—GSK3A—Alzheimer's disease	5.91e-06	5.52e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—BCHE—Alzheimer's disease	5.81e-06	5.42e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	5.66e-06	5.28e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—CTSD—Alzheimer's disease	5.63e-06	5.26e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—ACE—Alzheimer's disease	5.62e-06	5.25e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	5.48e-06	5.12e-05	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—CREB1—Alzheimer's disease	5.48e-06	5.12e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	5.3e-06	4.95e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—GSK3A—Alzheimer's disease	5.27e-06	4.92e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	5.23e-06	4.88e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	5.05e-06	4.71e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—ACE—Alzheimer's disease	5.02e-06	4.69e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	4.95e-06	4.62e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	4.88e-06	4.56e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	4.82e-06	4.5e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	4.8e-06	4.48e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	4.73e-06	4.41e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—IGF2—Alzheimer's disease	4.5e-06	4.2e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	4.48e-06	4.18e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—TPI1—Alzheimer's disease	4.43e-06	4.14e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CHAT—Alzheimer's disease	4.43e-06	4.14e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—DHCR24—Alzheimer's disease	4.38e-06	4.09e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	4.3e-06	4.02e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—MAOB—Alzheimer's disease	4.25e-06	3.97e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GAPDH—Alzheimer's disease	4.09e-06	3.82e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	4.04e-06	3.78e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—IGF2—Alzheimer's disease	4.01e-06	3.75e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	4.01e-06	3.74e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CHAT—Alzheimer's disease	3.95e-06	3.69e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—TPI1—Alzheimer's disease	3.95e-06	3.69e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—A2M—Alzheimer's disease	3.95e-06	3.69e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	3.95e-06	3.69e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—MAOB—Alzheimer's disease	3.79e-06	3.54e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CA4—Alzheimer's disease	3.72e-06	3.48e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GAPDH—Alzheimer's disease	3.65e-06	3.41e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	3.61e-06	3.37e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	3.57e-06	3.34e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—A2M—Alzheimer's disease	3.52e-06	3.29e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	3.52e-06	3.29e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	3.5e-06	3.27e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—LEP—Alzheimer's disease	3.49e-06	3.26e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—INPP5D—Alzheimer's disease	3.4e-06	3.17e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	3.33e-06	3.11e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	3.32e-06	3.1e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—F2—Alzheimer's disease	3.29e-06	3.08e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ENO1—Alzheimer's disease	3.22e-06	3.01e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTGS1—Alzheimer's disease	3.22e-06	3.01e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PLD3—Alzheimer's disease	3.16e-06	2.95e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP2D6—Alzheimer's disease	3.16e-06	2.95e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	3.14e-06	2.93e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—LEP—Alzheimer's disease	3.12e-06	2.91e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ACHE—Alzheimer's disease	3.06e-06	2.86e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	3.03e-06	2.83e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—INPP5D—Alzheimer's disease	3.03e-06	2.83e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—BCHE—Alzheimer's disease	2.99e-06	2.79e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—INS—Alzheimer's disease	2.98e-06	2.79e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—F2—Alzheimer's disease	2.94e-06	2.74e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—CCL2—Alzheimer's disease	2.94e-06	2.74e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	2.92e-06	2.73e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—IGF1—Alzheimer's disease	2.89e-06	2.7e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ENO1—Alzheimer's disease	2.87e-06	2.68e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTGS1—Alzheimer's disease	2.87e-06	2.68e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	2.86e-06	2.67e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PLCB1—Alzheimer's disease	2.82e-06	2.64e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ND1—Alzheimer's disease	2.82e-06	2.63e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP2D6—Alzheimer's disease	2.82e-06	2.63e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.77e-06	2.59e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ABCA1—Alzheimer's disease	2.74e-06	2.56e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—INS—Alzheimer's disease	2.66e-06	2.49e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—CCL2—Alzheimer's disease	2.62e-06	2.45e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—IGF1—Alzheimer's disease	2.57e-06	2.4e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PLCB1—Alzheimer's disease	2.52e-06	2.35e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.47e-06	2.31e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ABCA1—Alzheimer's disease	2.44e-06	2.28e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CA4—Alzheimer's disease	2.43e-06	2.27e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PPARGC1A—Alzheimer's disease	2.36e-06	2.2e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—HMOX1—Alzheimer's disease	2.35e-06	2.19e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	2.29e-06	2.14e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	2.17e-06	2.03e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—LPL—Alzheimer's disease	2.15e-06	2.01e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PPARGC1A—Alzheimer's disease	2.1e-06	1.97e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—HMOX1—Alzheimer's disease	2.09e-06	1.96e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PLD3—Alzheimer's disease	2.07e-06	1.93e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.98e-06	1.85e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—MTHFR—Alzheimer's disease	1.93e-06	1.81e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—LPL—Alzheimer's disease	1.92e-06	1.79e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.91e-06	1.78e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.84e-06	1.72e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—TPI1—Alzheimer's disease	1.82e-06	1.7e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CHAT—Alzheimer's disease	1.82e-06	1.7e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CALM1—Alzheimer's disease	1.81e-06	1.69e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—APOE—Alzheimer's disease	1.8e-06	1.68e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CAV1—Alzheimer's disease	1.78e-06	1.67e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—MAOB—Alzheimer's disease	1.74e-06	1.63e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—MTHFR—Alzheimer's disease	1.73e-06	1.61e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	1.68e-06	1.57e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—A2M—Alzheimer's disease	1.62e-06	1.51e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CALM1—Alzheimer's disease	1.61e-06	1.51e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—APOE—Alzheimer's disease	1.61e-06	1.5e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CAV1—Alzheimer's disease	1.59e-06	1.49e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PPARG—Alzheimer's disease	1.57e-06	1.46e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—INS—Alzheimer's disease	1.54e-06	1.44e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ACHE—Alzheimer's disease	1.41e-06	1.32e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PPARG—Alzheimer's disease	1.4e-06	1.31e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	1.39e-06	1.3e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—INS—Alzheimer's disease	1.37e-06	1.28e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NOS3—Alzheimer's disease	1.35e-06	1.26e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ENO1—Alzheimer's disease	1.32e-06	1.23e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	1.32e-06	1.23e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTGS2—Alzheimer's disease	1.23e-06	1.15e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—BCHE—Alzheimer's disease	1.23e-06	1.15e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NOS3—Alzheimer's disease	1.2e-06	1.12e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.19e-06	1.11e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.19e-06	1.11e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	1.16e-06	1.08e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.14e-06	1.06e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	1.12e-06	1.05e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTGS2—Alzheimer's disease	1.1e-06	1.03e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.1e-06	1.02e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.06e-06	9.89e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	9.68e-07	9.04e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	9.63e-07	9e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	9.21e-07	8.6e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	9.11e-07	8.5e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—LPL—Alzheimer's disease	8.81e-07	8.23e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	8.63e-07	8.06e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	8.63e-07	8.06e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	8.47e-07	7.91e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	8.03e-07	7.49e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	7.93e-07	7.41e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	7.57e-07	7.07e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	7.41e-07	6.92e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—APOE—Alzheimer's disease	7.38e-07	6.9e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	7.34e-07	6.85e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	7.32e-07	6.83e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	6.43e-07	6.01e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	6.33e-07	5.91e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—INS—Alzheimer's disease	6.31e-07	5.89e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	6.3e-07	5.88e-06	CbGpPWpGaD
Galantamine—ACHE—Metabolism—AKT1—Alzheimer's disease	6.2e-07	5.79e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—LPL—Alzheimer's disease	5.76e-07	5.38e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	5.53e-07	5.17e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—AKT1—Alzheimer's disease	5.53e-07	5.17e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	5.19e-07	4.84e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	5.06e-07	4.73e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	4.85e-07	4.52e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—APOE—Alzheimer's disease	4.83e-07	4.51e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	4.78e-07	4.47e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	4.21e-07	3.93e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—INS—Alzheimer's disease	4.12e-07	3.85e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	3.62e-07	3.38e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	3.31e-07	3.09e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	2.54e-07	2.37e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.66e-07	1.55e-06	CbGpPWpGaD
